Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 12, 2023

Real-World Treatment Patterns and Outcomes Associated With Sequential and Non-Sequential Use of CDK4/6 Inhibitors in Patients With HR+ HER2− MBC

Breast Cancer Research and Treatment


Additional Info

Disclosure statements are available on the authors' profiles:

Breast Cancer Research and Treatment
Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2- MBC in the real world
Breast Cancer Res Treat 2023 Aug 01;201(1)105-115, M Kruse, EN Smyth, L Bowman, S Gautam, CM Guimaraes, AR Nisbett, MD Fisher, ZL Cui, KM Sheffield, K Kalinsky

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading